Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following

Charu Venkatesan1, MaryAnn Chrzaszcz, Nicole Choi

  • 1Division of Neurology, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60614, USA. cvenkatesan@childrensmemorial.org

Abstract

Insights

Activated microglia expressing galectin-3/Mac-2 are crucial in diffuse axonal injury following traumatic brain injury. These cells are involved in myelin phagocytosis and release nerve growth factor, impacting brain recovery.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Traumatic brain injury (TBI) can cause diffuse axonal injury (DAI), leading to significant cognitive deficits.
  • Microglial activation is implicated in DAI, but its specific role and the heterogeneity of microglial responses remain unclear.
  • This study investigates the role of galectin-3/Mac-2 expressing microglia in DAI pathogenesis.

Purpose of the Study:

  • To test the hypothesis that microglia expressing galectin-3/Mac-2 are upregulated following diffuse axonal injury.
  • To determine if these specific microglia are involved in myelin phagocytosis.
  • To explore the role of galectin-3/Mac-2+ microglia in the chronic and acute phases of DAI.

Main Methods:

  • Adult mice underwent midline closed skull injury or sham procedures.
  • Immunohistochemistry and immunofluorescence were used to analyze microglial activation and lectin expression in the corpus callosum.
  • Samples were collected at 1, 8, 14, and 28 days post-injury.

Main Results:

  • Galectin-3/Mac-2 positive microglia were most abundant one day after injury.
  • Elevated levels of these microglia persisted compared to sham controls throughout the study period.
  • Most galectin-3/Mac-2+ microglia also expressed nerve growth factor.

Conclusions:

  • Galectin-3/Mac-2 expressing microglia are integral to the pathogenesis of DAI.
  • These microglia contribute to both acute and chronic injury processes.
  • Nerve growth factor release by galectin-3/Mac-2+ microglia is a key mechanism in DAI.